Hum. Reprod. Advance Access published online on February 14, 2006
Human Reproduction, doi:10.1093/humrep/del020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Infertility & IVF, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
* To whom correspondence should be addressed. BACKGROUND: Adding metformin to clomiphene citrate in clomiphene-resistant polycystic ovary syndrome (PCOS) patients increases ovulatory response. However, because of anti-estrogenic effects of clomiphene it may be associated with lower pregnancy rate, offsetting the ovulation rate benefit. Letrozole is an aromatase inhibitor which induces ovulation without anti-estrogenic effects. METHODS: Infertile women with PCOS were randomly divided into metformin-letrozole (29 patients) and metformin-clomiphene groups (30 patients). After an initial 6-8 weeks of metformin, they received either letrozole (2.5 mg) or clomiphene (100 mg) from day 3-7 of their menstrual cycle. Estradiol (E2) levels, number of follicles, pregnancy rates and endometrial thickness were measured on the day of HCG administration. RESULTS: Mean total E2 and E2 per mature follicle were significantly higher in clomiphene group without a difference in mean number of mature follicles >18 mm and ovulation rate. Endometrial thickness was significantly higher in letrozole group. The pregnancy rate in letrozole group (10 patients, 34.50%) as compared with clomiphene group (5 patients, 16.67%) did not show significant difference, whereas full-term pregnancies were higher in letrozole group [10 patients (34.50%) versus 3 patients (10%)]. CONCLUSION: In clomiphene-resistant PCOS patients, the combination of letrozole and metformin leads to higher full-term pregnancies.
Received July 27, 2005
Revised December 3, 2005
Accepted January 13, 2006
Article
Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease
F. Sohrabvand 1 *,
Sh. Ansari 1,
and
M. Bagheri 1
F. Sohrabvand, E-mail: fsohrabvand{at}yahoo.com
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. R Eckmann and D. R Kockler Aromatase Inhibitors for Ovulation and Pregnancy in Polycystic Ovary Syndrome Ann. Pharmacother., July 1, 2009; 43(7): 1338 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocr. Rev., February 1, 2009; 30(1): 1 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Requena, J. Herrero, J. Landeras, E. Navarro, J. L. Neyro, C. Salvador, R. Tur, J. Callejo, M. A. Checa, M. Farre, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis Hum. Reprod. Update, November 1, 2008; 14(6): 571 - 582. [Abstract] [Full Text] [PDF] |
||||


